Probiotic strains as systemic biological anti-inflammatory agents [Articol]

dc.contributor.authorBorshchev, Yurien
dc.contributor.authorBurovenko, Inessaen
dc.contributor.authorBorshcheva, Olgaen
dc.contributor.authorProtsak, Egoren
dc.contributor.authorBorshchev, Viktoren
dc.contributor.authorGalagudza, Mihailen
dc.date.accessioned2025-02-04T08:57:21Z
dc.date.issued2024
dc.description.abstractTherapeutic control of the intensity, duration, and quality of immune-inflammatory processes is fundamental to the successful treatment of most infectious and non-infectious diseases, including autoimmune disorders. The aim of this study was to investigate the anti-inflammatory potential of probiotic strains. In an experiment on male Wistar rats using a model of systemic inflammatory response syndrome (SIRS), significant reductions in key inflammatory markers such as TNF-α, IL-1, IL-12, IFN-γ, and MCP-1 were observed following the administration of a probiotic mix of L. acidophilus (LA-5) and B. animalis subsp. lactis (BB-12), as well as the isolated strain L. delbrueckii TS1-06. Improvements in myocardial functional indicators, behavioral responses, and accelerated reparative and regenerative processes were noted, suggesting the potential of these probiotic strains as candidates for therapeutic agents used as slow-acting anti-inflammatory drugs. en
dc.description.provenanceSubmitted by faureanu tanea (erika.bcu@gmail.com) on 2025-02-04T08:57:21Z No. of bitstreams: 1 3_Borshchev Yuri.pdf: 349604 bytes, checksum: b303a72bdee10697d2e97267b21be151 (MD5)en
dc.description.provenanceMade available in DSpace on 2025-02-04T08:57:21Z (GMT). No. of bitstreams: 1 3_Borshchev Yuri.pdf: 349604 bytes, checksum: b303a72bdee10697d2e97267b21be151 (MD5) Previous issue date: 2024en
dc.description.sponsorshipThis research was funded by a grant from the Russian Science Foundation (project No. 23-15-00139), https://rscf.ru/project/23-15- 00139.en
dc.identifier.citationBORSHCHEV Yuri; Inessa BUROVENKO; Olga BORSHCHEVA; Egor PROTSAK; Viktor BORSHCHEV and Mihail GALAGUDZA. Probiotic strains as systemic biological anti-inflammatory agents. In: Fiziologia şi sănătatea: materialele congresului VIII al fiziologilor din Republica Moldova cu participare internaţională, 14-15 noiembrie 2024. Chişinău: Editura USM, 2024, pp. 33-40. ISBN 978-9975-62-815-0; ISBN 978-9975-62-816-7 (PDF). Disponibil: https://doi.org/10.52692/cfzl2024.03en
dc.identifier.doihttps://doi.org/10.52692/cfzl2024.03
dc.identifier.isbn978-9975-62-815-0
dc.identifier.isbn978-9975-62-816-7 (PDF)
dc.identifier.urihttps://msuir.usm.md/handle/123456789/16603
dc.identifier.urihttps://doi.org/10.52692/cfzl2024.03
dc.language.isoen
dc.publisherEditura USM
dc.subjectProbioticsen
dc.subjectimmunityen
dc.subjectinflammationen
dc.subjectcytokinesen
dc.titleProbiotic strains as systemic biological anti-inflammatory agents [Articol]en
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
03_Borshchev Yuri.pdf
Size:
341.41 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:

Collections